Average Time to Initiation of Antiretroviral Therapy - Newly Diagnosed HIV Patients - University of Utah
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
As HIV elimination activities increase, jurisdictions can address HIV/Hepatitis C (HCV) co-infection by enhancing HCV screening and treatment data collection. This session will discuss NASTAD's work with North Carolina to incorporate HCV data in CAREWare and electronic health records (EHRs), as well as recommendations for integrating HCV services into the HIV care infrastructure.
Resource (Conference Presentation) updated 09/14/2023
Rapid has developed into a core feature of the Dorothy Mann Center HIV care continuum, assuring immediate linkage to expert HIV services, immediate initiation of therapy, and rapid viral suppression. Benefits are present for youth prevention services. Rapid access models are feasible and beneficial for youth HIV care and prevention.
Resource (Conference Presentation) updated 09/14/2023
This session will explain how Texas collects gender identity data for people with HIV and will examine disparities in care and health outcomes for transgender Texans living with HIV with an additional focus on the Latinx and black communities in order to understand how to better meet the needs of transgender people with HIV.
Resource (Conference Presentation) updated 09/14/2023
A clinic-based substance abuse screening and treatment program is described. Using the Screening, Brief Intervention, and Referral to Treatment model, this provides annual proactive screening of alcohol/drug use, with a brief provider response and a follow-up motivational interviewing brief intervention, with treatment provided by an embedded provider.
Resource (Conference Presentation) updated 09/14/2023
Oklahoma has been classified by the Department of Health and Human Services as one of the seven states with a high rural HIV burden. Test-and-treat protocols are feasible within high-volume HIV clinics which serve rural and underserved communities to minimize the time to the first appointment to decrease time to viral load suppression.
Resource (Conference Presentation) updated 09/14/2023
Transgender women, especially those of color, have substantially lower rates of viral suppression than people with HIV in general. The New York City HIV Planning Council collaborated with the community to develop guiding recommendations that drove the development of the jurisdiction's first psycho-social service directive specifically for people of transgender, intersex, non-binary, and/or non-conforming experience.
Resource (Conference Presentation) updated 09/14/2023
This workshop will explore the implementation of peer-led, evidence-informed interventions for transgender women with HIV. The programs are Healthy Divas, and Transgender Women Engagement and Entry to Care Project (T.W.E.E.T.). Attendees will learn the core elements of these interventions and how they improve engagement in care, treatment adherence, and viral suppression in Alabama and Michigan.
Resource (Conference Presentation) updated 09/14/2023
This session will help recipient and subrecipient sites to successfully connect their CAREWare and other electronic health information systems with external sources of data to report and monitor HIV care and treatment outcomes. This session will provide practical examples of successful data integration and highlight ongoing issues and costs in long-term management and maintenance.
Resource (Conference Presentation) updated 09/14/2023
The presentation will describe how CAREWare and eligibility integration eased access to services by clients in our jurisdictions. Presenters will be to provide Ryan White jurisdictions with actionable ideas and processes to integrate their CAREWare and eligibility processes to improve access to services, reporting, monitoring, and quality management.
Resource (Conference Presentation) updated 09/14/2023
In 2019, the Louisiana AIDS Drug Assistance Program (ADAP) partnered with a leading private dental insurer to design a group dental plan modeled after an employer-sponsored plan, specifically tailored to the needs of people with HIV. Both utilization and client satisfaction rose significantly following the adoption of the plan.
Resource (Conference Presentation) updated 09/14/2023
Presenters will describe a medical community collaboration to resolve care gaps and improve patient health outcomes through the co-location of health home care management by a community-based organization (CBO) within medical clinics. Panel members will share successes and challenges of implementation of the project and integrating a CBO care team into a medical clinic.
Resource (Conference Presentation) updated 09/14/2023
CAREWare users can provide input on all CAREWare 6 software components, including ease of use, design, reports, and other features. This session will address challenges with specific features like setup, administration, generating reports, and basic data entry.
Resource (Conference Presentation) updated 09/14/2023
This session will focus on key findings and behavioral considerations for long-acting antiretroviral treatment (ART) HIV regimens, given the progress in research, development, and potential approval of these drugs. There will be a brief overview of the ATLAS and FLAIR studies, discussion of the medications, and an outline of the potential impact of the regimens on care delivery models, providers, patients, and payers if they are approved.
Resource (Conference Presentation) updated 09/14/2023
Rapid initiation of antiretroviral therapy (ART) after diagnosis can increase the number of patients arriving for appointments, shorten time to viral suppression, and promote health equity. The presenters share key lessons learned through the implementation process at a large HIV clinic in the South with the theme of partnerships.
Resource (Conference Presentation) updated 09/14/2023
In December 2016 CrescentCare began linking individuals newly diagnosed with within 72-hours through the CrescentCare START Initiative. We compared linkage and viral suppression between those under and over 24 years old. We found similar successful outcomes for both age cohorts in our intervention.
Resource (Conference Presentation) updated 09/14/2023
Implementation of rapid antiretroviral therapy (ART) initiation is beset with clinical and process challenges. Three clinical providers will share their lessons learned from developing a program and delivering care in various care settings (pediatric, adult, and walk-in clinic).
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 12/11/2023